Monday, July 23, 2018

Revenue Cycle Management Market Worth 90.43 Billion USD by 2022



Revenue cycle management (RCM) in healthcare industry has fast become a buzzword over the past few years. It enables the healthcare organizations to manage payments, claims processing, and revenue generation, thereby accelerating the whole revenue cycle in an efficient manner. RCM solution begins when a patient enters or schedules an appointment. It automates the whole procedure with initiation of the process by the patient, quick follow ups, determining the eligibility of the patient, collecting their payment, effective tracking of the claims process, and working on rejected claims among others. The rising need for streamlining the whole process has further boosted the demand for RCM solutions, thereby triggering the growth of the RCM market.
 
Browse 104 market data Tables and 31 Figures spread through 168 Pages and in-depth TOC on "Revenue Cycle Management Market".

https://www.marketsandmarkets.com/Market-Reports/revenue-cycle-management-market-153900104.html

Early buyers will receive 10% customization on reports

Regulatory mandates for the adoption of EHR/EMR and government initiatives to boost the adoption of RCM solutions are the major factors driving the adoption of RCM solutions.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=153900104

Based on product, the integrated solutions segment is accounted for the largest share of the market in 2017
On the basis of product, the market is broadly segmented into integrated and standalone solutions. The integrated solutions segment is expected to account for the largest share of the global revenue cycle management market in 2017 and is projected to register the highest CAGR during the forecast period. Growth in this segment can be attributed to the rising adoption of value-based payment systems and the growing demand for cost-saving data management solutions.

Based on function, the claim and denial management segment is accounted for the largest share of the market in 2017
On the basis of function, the market is broadly segmented into claim and denial management, medical billing and coding, patient insurance eligibility check, payment remittance, electronic health record (EHR), clinical documentation improvement (CDI), and others. The claim and denial management segment is expected to account for the largest share of the global revenue cycle management market in 2017 and is expected to witness the highest CAGR during the forecast period. The growing demand for claims and denial management due to the dynamic reimbursement structure and the increasing instances of claim denials are the major factors driving the growth of this segment.

North America is expected to dominate the market in 2017
In 2017, North America is expected to account for the largest share of the global revenue cycle management market. The large share of this regional segment can be attributed to stringent legislative and accreditation requirements regarding healthcare, high adoption rate of HCIT technologies, and regulatory requirements regarding patient safety. Europe is expected to account for the second-largest share of the revenue cycle management market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=153900104

Key Market Players:
The key players in the Global Revenue Cycle Management Market are McKesson (US), Cerner (US), Quest Diagnostics (US), Allscripts Health Solutions (US), and athenahealth (US).

Browse Related Reports:

North American Healthcare IT Market by Product (EHR, RIS, PACS, VNA, CPOE, mHealth, Telehealth, Healthcare analytics, Supply Chain Management, Revenue Cycle Management, CRM, Claims Management) by End User (Provider, Payer ) - Forecast to 2020 

For more Insights: https://www.marketsandmarkets.com/Market-Reports/north-america-healthcare-it-market-1190.html

 

About MarketsandMarkets™  
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com


 

No comments:

Post a Comment

Pharmaceutical Filtration Market: Recent Trends and Developments

  Growth in the pharmaceutical filtration market can be attributed to factors such as rapid growth in the R&D and manufacturing of bioph...